Manufacturer record

Pro Laboratories Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Pro Laboratories Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between February 2022 and June 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: CAG-21014, Omeprazole Capsules IP 20mg. (exp Dec 2022). RDTL Guwahati (state lab) found it not of standard quality: Dissolution. Listed in the June 2022 alert.

Records by type

2 records linked to Pro Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2022 to Jun 2022

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2022
1
Products affected
Dissolution
Most common failure
Jun 2022
Latest alert

Flagged batches per year

2022 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Omeprazole Capsules IP 20mg. Batch CAG-21014Mfg Jan 2021 · Exp Dec 2022 DissolutionDissolution RDTL GuwahatiState lab Jun 2022
Omeprazole Capsules IP 20 mg Batch CAG-21010Mfg Jan 2021 · Exp Dec 2022 DissolutionDissolution RDTL GuwahatiCDSCO lab Feb 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.